Cyclo Therapeutics : Corporate Presentation
NASDAQ: CYTH cyclotherapeutics.com Forward-Looking Statements 2 ...
Source: marketscreener.com
Extension Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Extension Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Extension Study Today - Breaking & Trending Today
Cassava Sciences Reports Full-year 2023 Financial Results
$121.1 Million In Cash and Cash Equivalents at December 31, 2023, With an Additional $21.8 Million Raised In 2024 From Exercise of Warrants.A Total of Over...
Source: globenewswire.com
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
19.12.2023 - WARRINGTON, PA / ACCESSWIRE / December 19, 2023 / Windtree Therapeutics, Inc. (NASDAQ:WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the treatment of early cardiogenic shock. The phase ...
Source: wallstreet-online.de
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock ...
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock ...
Source: pr-inside.com
Clearside Biomedical's Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual Meeting -November 07, 2023 at 04:20 pm EST
ALPHARETTA, Ga., Nov. 07, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,...
Source: marketscreener.com